Leader in Biotechnological Solutions

Yerlika Pharmaceutical Industry and Trade Inc. offers innovative solutions in biotechnological drug production with its CMO and CDMO services. With extensive production capacity, flexible filling lines, and wave-type bioreactor technology, it provides tailored manufacturing capabilities for monoclonal antibodies, vaccines, peptides, gene therapies, and viral vector-based products.

In addition, it simplifies the transition from laboratory-scale to commercial production with services in process development, formulation solutions, and product development. Yerlika ensures reliable partnerships through documentation and audit support compliant with national and international regulations.

Secure the future of biotechnology with Yerlika Pharmaceutical Industry and Trade Inc.

Extensive Production Capacity

Upstream and downstream processes using wave-type and single-use bioreactors

Flexible Filling Lines

Filling liquid and lyophilized products in vials, cartridges, and syringes

Diverse Product Portfolio

Custom manufacturing for monoclonal antibodies, recombinant proteins, vaccines, peptides, gene therapies, and viral vector-based products

Process Development

Optimization and scaling of biopharmaceutical production processes using mammalian cell lines

Formulation Development:

Tailored formulation solutions for your products, lyophilization process development, buffer, and excipient optimization

Product Development

Support through the transition from laboratory scale to commercial production

Regulatory Support

Documentation and audit processes aligned with national and international standards